BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31165515)

  • 1. Gastric bypass surgery in the treatment of gastro-oesophageal reflux symptoms.
    Holmberg D; Santoni G; Xie S; Lagergren J
    Aliment Pharmacol Ther; 2019 Jul; 50(2):159-166. PubMed ID: 31165515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux.
    Maret-Ouda J; Wahlin K; El-Serag HB; Lagergren J
    JAMA; 2017 Sep; 318(10):939-946. PubMed ID: 28898377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid suppression medications are associated with suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass in patients older than 40 years.
    Ward EK; Jensen-Otsu E; Schoen JA; Rothchild K; Mitchell B; Austin GL
    Surg Obes Relat Dis; 2015; 11(3):585-90. PubMed ID: 25553887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort.
    Thereaux J; Lesuffleur T; Czernichow S; Basdevant A; Msika S; Nocca D; Millat B; Fagot-Campagna A
    Surg Obes Relat Dis; 2017 Jun; 13(6):951-959. PubMed ID: 28223087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss.
    Lin BM; Curhan SG; Wang M; Jacobson BC; Eavey R; Stankovic KM; Curhan GC
    Ear Hear; 2017; 38(1):21-27. PubMed ID: 27556519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderating the Enthusiasm of Sleeve Gastrectomy: Up to Fifty Percent of Reflux Symptoms After Ten Years in a Consecutive Series of One Hundred Laparoscopic Sleeve Gastrectomies.
    Mandeville Y; Van Looveren R; Vancoillie PJ; Verbeke X; Vandendriessche K; Vuylsteke P; Pattyn P; Smet B
    Obes Surg; 2017 Jul; 27(7):1797-1803. PubMed ID: 28190216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease.
    Lambert R
    Aliment Pharmacol Ther; 1997 Aug; 11(4):651-62. PubMed ID: 9305472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass is Effective for Gastro-Oesophageal Reflux Disease but not for Further Weight Loss.
    Parmar CD; Mahawar KK; Boyle M; Schroeder N; Balupuri S; Small PK
    Obes Surg; 2017 Jul; 27(7):1651-1658. PubMed ID: 28063112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].
    Vallot T; Ducrotte P; Bour B; Jacques JP; Houcke P; De Korwin JD; Pariente A; Aygalenq P; Coudsy B; Carrois F; Ricci L; Bruley des Varannes S
    Presse Med; 2013 May; 42(5):e125-32. PubMed ID: 23414966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
    Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
    Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow up in patients with gastroesophageal reflux disease with specific emphasis on reflux symptoms, use of anti-reflux medication and anti-reflux surgery outcome: a retrospective study.
    Van Meer S; Bogte A; Siersema PD
    Scand J Gastroenterol; 2013 Nov; 48(11):1242-8. PubMed ID: 24041112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in utilization of acid-reducing medication at 1 year following bariatric surgery: results from the Michigan Bariatric Surgery Collaborative.
    Varban OA; Hawasli AA; Carlin AM; Genaw JA; English W; Dimick JB; Wood MH; Birkmeyer JD; Birkmeyer NJ; Finks JF
    Surg Obes Relat Dis; 2015; 11(1):222-8. PubMed ID: 24981934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic Roux-en-Y Gastric Bypass After Gastroesophageal Reflux Disease Surgical Procedure: Analysis of 85 Consecutive Patients with Pre- and Post-Operative Endoscopy Control.
    Baretta G; Al-Mulla AE; Lopes MAG; Feistler RS; Cambi MPC; de Paula Loureiro M
    J Laparoendosc Adv Surg Tech A; 2020 Jan; 30(1):40-43. PubMed ID: 31368842
    [No Abstract]   [Full Text] [Related]  

  • 15. Barrett's esophagus before and after Roux-en-Y gastric bypass for severe obesity.
    Andrew B; Alley JB; Aguilar CE; Fanelli RD
    Surg Endosc; 2018 Feb; 32(2):930-936. PubMed ID: 28779257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis.
    You JH; Lee AC; Wong SC; Chan FK
    Aliment Pharmacol Ther; 2003 Mar; 17(6):785-92. PubMed ID: 12641500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-oesophageal reflux disease: variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptoms.
    Egan LJ; Myhre GM; Mays DC; Dierkhising RA; Kammer PP; Murray JA
    Aliment Pharmacol Ther; 2003 Jun; 17(12):1521-8. PubMed ID: 12823155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GERD: Diagnosing and treating the burn.
    Alzubaidi M; Gabbard S
    Cleve Clin J Med; 2015 Oct; 82(10):685-92. PubMed ID: 26469826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.